Penny stock below ₹10 considers Singapore-based firms' proposal for 25% stake acquisition. Details here
Welcure Drugs & Pharmaceuticals has received a letter of intent from Singapore's Telexcell to acquire a 25% stake. While the proposal shows potential growth, the company insists on maintaining its management independence, ensuring a balance between foreign investment and shareholder interests.
Welcure Drugs & Pharmaceuticals has received a letter of intent from Singapore's Telexcell to acquire a 25% stake. While the proposal shows potential growth, the company insists on maintaining its management independence, ensuring a balance between foreign investment and shareholder interests.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
